Targeted therapy with trastuzumab for epidermal growth factor receptor 2 (HER2)-positive advanced salivary duct carcinoma: A case report

Herein we report two cases of advanced and/or metastatic salivary duct carcinoma that relapsed after standard first-line chemotherapy. As overexpression of human epidermal growth factor receptor 2 (HER2) (3+) was observed by immunohistochemistry, the patients were treated with trastuzumab plus pacli...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibo, Takahiko, Sekiguchi, Nodoka, Gomi, Daisuke, Noguchi, Takuro, Fukushima, Toshirou, Kobayashi, Takashi, Ozawa, Takesumi, Yamada, Shin-Ichi, Koizumi, Tomonobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589940/
https://www.ncbi.nlm.nih.gov/pubmed/31281644
http://dx.doi.org/10.3892/mco.2019.1875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589940/
https://www.ncbi.nlm.nih.gov/pubmed/31281644
http://dx.doi.org/10.3892/mco.2019.1875

Ejemplares similares